ArticleCancer chemotherapy and pharmacology2025

Sacituzumab Govitecan initial dose reduction in polish patients with metastatic triple-negative breast cancer: impact on efficacy and safety.

Małgorzata Pieniążek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.